Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ANIP | US
0.33
0.57%
Healthcare
Biotechnology
30/06/2024
04/10/2024
57.83
57.61
58.30
57.44
ANI Pharmaceuticals Inc. a biopharmaceutical company develops manufactures and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances oncology products hormones and steroids injectables and other formulations including extended release and combination products. The company manufactures oral solid dose products; semi-solids liquids and topicals; and potent products as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains wholesalers distributors and mail order pharmacies and group purchasing organizations. ANI Pharmaceuticals Inc. was incorporated in 2001 and is headquartered in Baudette Minnesota.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Smallcap (300M - 2B USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
28.5%1 month
46.2%3 months
44.4%6 months
38.0%49.40
9.63
2.71
0.68
0.34
11.13
2.41
1.06
107.97M
1.22B
1.22B
-
6.54
1.38K
18.40
5.90
6.01
13.69
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
4.12
Range1M
11.19
Range3M
13.98
Rel. volume
0.18
Price X volume
4.30M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals Inc | TARS | Biotechnology | 33.89 | 1.31B | 3.48% | n/a | 28.62% |
ELVN | ELVN | Biotechnology | 27.53 | 1.30B | 8.81% | n/a | 0.06% |
Avadel Pharmaceuticals plc | AVDL | Biotechnology | 13.09 | 1.26B | 0.23% | n/a | 53.59% |
Mesoblast Limited | MESO | Biotechnology | 10.81 | 1.26B | 23.40% | n/a | 24.76% |
Wave Life Sciences Ltd | WVE | Biotechnology | 8.41 | 1.24B | -4.76% | n/a | 656.70% |
Innoviva Inc | INVA | Biotechnology | 19.67 | 1.23B | 0.56% | 10.92 | 67.72% |
Fluent Inc | COGT | Biotechnology | 11.11 | 1.22B | 3.64% | n/a | 4.87% |
PHATHOM PHARMACEUTICALS INC. | PHAT | Biotechnology | 17.25 | 1.20B | 2.92% | n/a | -216.56% |
ARCUTIS BIOTHERAPEUTICS INC. | ARQT | Biotechnology | 10.02 | 1.17B | -2.05% | n/a | 111.34% |
Travere Therapeutics Inc. | TVTX | Biotechnology | 15.23 | 1.16B | 9.81% | n/a | 2662.08% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 11.13 | 0.76 | Expensive |
Ent. to Revenue | 2.41 | 3,674.48 | Cheaper |
PE Ratio | 49.40 | 38.01 | Expensive |
Price to Book | 2.71 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 44.36 | 74.67 | Lower Risk |
Debt to Equity | 0.68 | -1.82 | Expensive |
Debt to Assets | 0.34 | 0.26 | Expensive |
Market Cap | 1.22B | 3.73B | Emerging |